Is it time to buy Cannabis? Over the recent weeks, here on Equity Guru, I have been telling readers and discord members that the bottom may be in for…
tilray
It hasn’t been fun being invested in the Cannabis space recently. A lot of eyes have been on the US side of things. The catalyst being Federal deregulation. I…
What to say about Cannabis stocks. You give us some hope, and then pull the rug from under us. If you are a member of Equity Guru’s Free Trading…
Tilray (TLRY.T) announced that their wholly-owned German subsidiary Aphria RX GmbH has completed the first successful harvest of medical cannabis cultivated in Germany. The cannabis was delivered to German…
By all accounts, 2021 is gearing up to be an even stranger year than 2020 for stocks, traders and anyone looking to make a buck off the markets. We’ve…
Tilray (TLRY.Q) is up 37% today after inking an importation and distribution agreement with Grow Pharma to get their medical cannabis products into the United Kingdom markets, according to…
Medipharm Labs (LABS.T), like the rest of cannabis industry, has seen better days. Their price has rode a deteriorating wave to a little over a buck from their last…
Inner Spirit Holdings (ISH.C) announced that five of their franchise partners have secured retail store authorizations (RSA) for Spiritleaf cannabis stores in Toronto, Ottawa and Guelph, Ontario. The RSAs…
You will grow through what you go through. It sounds like one of those motivational platitudes spouted at high speed on whatever social networking platform you choose to frequent,…
If Tilray (TLRY.Q) will leave any sort of legacy on the Canadian cannabis landscape, it will be that, for a short time and by virtue of a well-timed and…